SYROS PHARMACEUTICALS, INC. Comprehensive Income
SYROS PHARMACEUTICALS, INC. reported Comprehensive Income of -$6.40 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2024-10-31
- SYROS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$6.40M.
- SYROS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-06-30 was -$23.33M.
- SYROS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-03-31 was -$3.71M.
- SYROS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-12-31 was -$64.38M.
- SYROS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$164.68M.
- SYROS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$94.47M.
- SYROS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$86.64M.
- SYROS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$84.06M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$6.40M 10-Q · filed 2024-10-31 | -$29.72M derived: sum of 2 quarters · filed 2024-10-31 | -$33.43M 10-Q · filed 2024-10-31 | -$97.81M derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | -$23.33M 10-Q · filed 2024-07-31 | -$27.04M 10-Q · filed 2024-07-31 | -$91.42M derived: sum of 3 quarters · filed 2024-07-31 | -$131.61M derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-03-31 | -$3.71M 10-Q · filed 2024-05-14 | -$68.09M derived: sum of 2 quarters · filed 2024-05-14 | -$108.28M derived: sum of 3 quarters · filed 2024-10-31 | -$144.76M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-12-31 | -$64.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$104.58M derived: sum of 2 quarters · filed 2024-10-31 | -$141.05M derived: sum of 3 quarters · filed 2024-10-31 | -$164.68M 10-K · filed 2024-03-27 |
| 2023-09-30 | -$40.19M 10-Q · filed 2024-10-31 | -$76.66M derived: sum of 2 quarters · filed 2024-10-31 | -$100.29M 10-Q · filed 2024-10-31 | -$104.74M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | -$36.47M 10-Q · filed 2024-07-31 | -$60.10M 10-Q · filed 2024-07-31 | -$64.55M derived: sum of 3 quarters · filed 2024-07-31 | -$94.71M derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | -$23.63M 10-Q · filed 2024-05-14 | -$28.07M derived: sum of 2 quarters · filed 2024-05-14 | -$58.24M derived: sum of 3 quarters · filed 2024-05-14 | -$92.76M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$4.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$34.61M derived: sum of 2 quarters · filed 2024-03-27 | -$69.13M derived: sum of 3 quarters · filed 2024-03-27 | -$94.47M 10-K · filed 2024-03-27 |
| 2022-09-30 | -$30.17M 10-Q · filed 2023-11-14 | -$64.69M derived: sum of 2 quarters · filed 2023-11-14 | -$90.03M 10-Q · filed 2023-11-14 | -$113.91M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$34.52M 10-Q · filed 2023-08-08 | -$59.86M 10-Q · filed 2023-08-08 | -$83.75M derived: sum of 3 quarters · filed 2023-08-08 | -$109.76M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$25.34M 10-Q · filed 2023-05-10 | -$49.23M derived: sum of 2 quarters · filed 2023-05-10 | -$75.24M derived: sum of 3 quarters · filed 2023-05-10 | -$97.75M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$23.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$49.90M derived: sum of 2 quarters · filed 2023-03-02 | -$72.41M derived: sum of 3 quarters · filed 2023-03-02 | -$86.64M 10-K · filed 2023-03-02 |
| 2021-09-30 | -$26.01M 10-Q · filed 2022-11-14 | -$48.52M derived: sum of 2 quarters · filed 2022-11-14 | -$62.75M 10-Q · filed 2022-11-14 | -$92.88M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | -$22.51M 10-Q · filed 2022-08-09 | -$36.74M 10-Q · filed 2022-08-09 | -$66.87M derived: sum of 3 quarters · filed 2023-03-02 | -$86.35M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | -$14.23M 10-Q · filed 2022-05-16 | -$44.36M derived: sum of 2 quarters · filed 2023-03-02 | -$63.84M derived: sum of 3 quarters · filed 2023-03-02 | -$81.04M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | -$30.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$49.62M derived: sum of 2 quarters · filed 2023-03-02 | -$66.81M derived: sum of 3 quarters · filed 2023-03-02 | -$84.06M 10-K · filed 2023-03-02 |
| 2020-09-30 | -$19.49M 10-Q · filed 2021-11-05 | -$36.69M derived: sum of 2 quarters · filed 2021-11-05 | -$53.93M 10-Q · filed 2021-11-05 | -$73.66M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | -$17.20M 10-Q · filed 2021-08-05 | -$34.45M 10-Q · filed 2021-08-05 | -$54.17M derived: sum of 3 quarters · filed 2022-03-15 | -$73.95M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | -$17.25M 10-Q · filed 2021-05-06 | -$36.97M derived: sum of 2 quarters · filed 2022-03-15 | -$56.75M derived: sum of 3 quarters · filed 2022-03-15 | -$76.21M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | -$19.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$39.50M derived: sum of 2 quarters · filed 2022-03-15 | -$58.96M derived: sum of 3 quarters · filed 2022-03-15 | -$75.41M 10-K · filed 2022-03-15 |
| 2019-09-30 | -$19.78M 10-Q · filed 2020-11-05 | -$39.23M derived: sum of 2 quarters · filed 2020-11-05 | -$55.69M 10-Q · filed 2020-11-05 | -$73.71M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | -$19.46M 10-Q · filed 2020-08-06 | -$35.91M 10-Q · filed 2020-08-06 | -$53.93M derived: sum of 3 quarters · filed 2021-03-04 | -$69.67M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | -$16.45M 10-Q · filed 2020-05-07 | -$34.47M derived: sum of 2 quarters · filed 2021-03-04 | -$50.22M derived: sum of 3 quarters · filed 2021-03-04 | -$64.23M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | -$18.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$33.77M derived: sum of 2 quarters · filed 2021-03-04 | -$47.78M derived: sum of 3 quarters · filed 2021-03-04 | -$62.24M 10-K · filed 2021-03-04 |
| 2018-09-30 | -$15.74M 10-Q · filed 2019-11-12 | -$29.76M derived: sum of 2 quarters · filed 2019-11-12 | -$44.22M 10-Q · filed 2019-11-12 | -$59.55M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | -$14.02M 10-Q · filed 2019-08-01 | -$28.48M 10-Q · filed 2019-08-01 | -$43.81M derived: sum of 3 quarters · filed 2020-03-05 | -$57.64M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | -$14.46M 10-Q · filed 2019-05-01 | -$29.79M derived: sum of 2 quarters · filed 2020-03-05 | -$43.62M derived: sum of 3 quarters · filed 2020-03-05 | -$56.98M derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | -$15.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | -$29.16M derived: sum of 2 quarters · filed 2020-03-05 | -$42.52M derived: sum of 3 quarters · filed 2020-03-05 | -$54.04M 10-K · filed 2020-03-05 |
| 2017-09-30 | -$13.83M 10-Q · filed 2018-11-01 | -$27.19M derived: sum of 2 quarters · filed 2018-11-01 | -$38.71M 10-Q · filed 2018-11-01 | -$49.68M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | -$13.36M 10-Q · filed 2018-08-07 | -$24.88M 10-Q · filed 2018-08-07 | -$35.85M derived: sum of 3 quarters · filed 2019-03-07 | -$50.02M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$11.52M 10-Q · filed 2018-05-10 | -$22.49M derived: sum of 2 quarters · filed 2019-03-07 | -$36.66M derived: sum of 3 quarters · filed 2019-03-07 | -$48.68M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | -$10.97M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$25.14M derived: sum of 2 quarters · filed 2019-03-07 | -$37.16M derived: sum of 3 quarters · filed 2019-03-07 | -$47.75M 10-K · filed 2019-03-07 |
| 2016-09-30 | -$14.17M 10-Q · filed 2017-11-08 | -$26.19M derived: sum of 2 quarters · filed 2017-11-08 | -$36.78M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | -$12.02M 10-Q · filed 2017-08-09 | -$22.61M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$10.59M 10-Q · filed 2017-05-15 | |||
| 2015-12-31 | -$29.82M 10-K · filed 2018-03-12 |